• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current landscape of cytoreductive nephrectomy: who, when, and why?

作者信息

Zeng Jiping, Harb-De la Rosa Alfredo, Chipollini Juan

机构信息

Division of Urology, Department of Surgery, The University of Arizona, Tucson, AZ, USA.

出版信息

Ann Transl Med. 2019 Jul;7(Suppl 3):S77. doi: 10.21037/atm.2019.04.03.

DOI:10.21037/atm.2019.04.03
PMID:31576286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6685835/
Abstract
摘要

相似文献

1
Current landscape of cytoreductive nephrectomy: who, when, and why?减瘤性肾切除术的现状：何人、何时以及为何进行？
Ann Transl Med. 2019 Jul;7(Suppl 3):S77. doi: 10.21037/atm.2019.04.03.
2
The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma.细胞减灭性肾切除术在转移性肾细胞癌中的不断演变的角色。
Curr Opin Urol. 2019 Sep;29(5):507-512. doi: 10.1097/MOU.0000000000000657.
3
Role of cytoreductive nephrectomy in renal cell carcinoma.细胞减灭性肾切除术在肾细胞癌中的作用。
Future Oncol. 2009 Aug;5(6):859-69. doi: 10.2217/fon.09.52.
4
Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era.在靶向治疗时代，分析术前变量以识别可能从转移性肾细胞癌先行细胞减灭性肾切除术中获益的患者。
Jpn J Clin Oncol. 2015 Jan;45(1):96-102. doi: 10.1093/jjco/hyu171. Epub 2014 Oct 23.
5
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.细胞减灭性肾切除术对接受血管内皮生长因子靶向治疗的转移性肾细胞癌患者生存的影响。
J Urol. 2011 Jan;185(1):60-6. doi: 10.1016/j.juro.2010.09.012. Epub 2010 Nov 12.
6
Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.减瘤性肾切除术在变异型组织学转移性肾细胞癌中的作用演变。
Curr Opin Urol. 2019 Sep;29(5):521-525. doi: 10.1097/MOU.0000000000000661.
7
Impact of Cytoreductive Nephrectomy on Survival in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy.减瘤性肾切除术对接受靶向治疗的转移性肾细胞癌患者生存的影响。
Chin Med J (Engl). 2016 Mar 5;129(5):530-5. doi: 10.4103/0366-6999.177001.
8
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma.初始细胞减灭性肾切除术与初始靶向治疗转移性肾细胞癌的生存比较。
J Urol. 2018 Sep;200(3):528-534. doi: 10.1016/j.juro.2018.03.077. Epub 2018 Mar 21.
9
Cytoreductive nephrectomy in metastatic renal cell carcinoma.转移性肾细胞癌的减瘤性肾切除术
Curr Opin Urol. 2008 Sep;18(5):474-80. doi: 10.1097/MOU.0b013e32830a4f21.
10
Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.接受减瘤性肾切除术的转移性肾细胞癌患者术后C反应蛋白水平的预后影响
J Urol. 2008 Aug;180(2):515-9. doi: 10.1016/j.juro.2008.04.025. Epub 2008 Jun 11.

本文引用的文献

1
Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial.舒尼替尼治疗同步转移性肾细胞癌患者中即刻与延迟细胞减瘤性肾切除术的比较：SURTIME 随机临床试验。
JAMA Oncol. 2019 Feb 1;5(2):164-170. doi: 10.1001/jamaoncol.2018.5543.
2
Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma.系统评价细胞减积性肾切除术在靶向治疗时代及以后的作用：转移性肾细胞癌的个体化治疗方法。
Eur Urol. 2019 Jan;75(1):111-128. doi: 10.1016/j.eururo.2018.09.016. Epub 2018 Oct 25.
3
Surgical Management of Advanced Kidney Cancer: The Role of Cytoreductive Nephrectomy and Lymphadenectomy.晚期肾癌的外科治疗：减瘤性肾切除术和淋巴结清扫术的作用
J Clin Oncol. 2018 Oct 29:JCO2018790246. doi: 10.1200/JCO.2018.79.0246.
4
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy.卡门娜真的应该改变我们对转移性肾细胞癌细胞减瘤性肾切除术的态度吗？一项系统评价和荟萃分析评估了靶向治疗时代的细胞减瘤性肾切除术。
Target Oncol. 2018 Dec;13(6):705-714. doi: 10.1007/s11523-018-0601-2.
5
External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.转移性肾细胞癌细胞减灭性肾切除术后生存预测模型的外部验证。
World J Urol. 2018 Dec;36(12):1973-1980. doi: 10.1007/s00345-018-2427-z. Epub 2018 Aug 1.
6
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.舒尼替尼单药治疗或肾细胞癌转移患者肾切除术后的治疗。
N Engl J Med. 2018 Aug 2;379(5):417-427. doi: 10.1056/NEJMoa1803675. Epub 2018 Jun 3.
7
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma.初始细胞减灭性肾切除术与初始靶向治疗转移性肾细胞癌的生存比较。
J Urol. 2018 Sep;200(3):528-534. doi: 10.1016/j.juro.2018.03.077. Epub 2018 Mar 21.
8
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.开发用于预测转移性肾细胞癌细胞减灭性肾切除术后生存的个体化准确模型。
Eur Urol. 2013 May;63(5):947-52. doi: 10.1016/j.eururo.2012.11.040. Epub 2012 Nov 23.
9
Prognostic factors and predictive models in renal cell carcinoma: a contemporary review.肾细胞癌的预后因素和预测模型：当代综述。
Eur Urol. 2011 Oct;60(4):644-61. doi: 10.1016/j.eururo.2011.06.041. Epub 2011 Jun 30.
10
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy.接受细胞减灭性肾切除术患者的系统治疗使用和影响生存的因素。
BJU Int. 2010 Jul;106(2):218-23. doi: 10.1111/j.1464-410X.2009.09079.x. Epub 2009 Nov 17.